Remove 2027 Remove Medical science Remove Patients
article thumbnail

Moving towards oral delivery of biologics

European Pharmaceutical Review

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. We have confirmed this in close to 100 subjects who have swallowed the RP.”

article thumbnail

What A Field Clinical Engineer In Neuromodulation Sales Does With Blake Williams

Evolve Your Success

Neuromodulation isn’t just about stimulating nerves; it’s about awakening hope and transforming lives—one patient at a time. In this episode, Blake Williams takes us on a wild journey through his career as a Field Clinical Engineer (FCE), shedding light on the incredible impact of neuromodulation on the lives of patients.

article thumbnail

Innovations in Cancer Research & Treatment: Leveraging Modern Technologies to Overcome Global Challenges

PM360

billion by 2027, growing at a CAGR of 25.8%. This interaction enables the immune effector cells to target and kill cancer cells more effectively, significantly benefiting patients. Hait’s insights on advancing innovation and collaboration in the fight against cancer. The global telemedicine market is projected to reach USD 396.76